What is the management of marijuana hyperemesis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Cannabinoid Hyperemesis Syndrome (CHS)

The definitive management of cannabinoid hyperemesis syndrome requires complete cannabis cessation for at least 3-6 months, along with supportive care including IV fluid rehydration, dopamine receptor antagonists (particularly haloperidol), and topical capsaicin application. 1

Diagnosis

CHS should be suspected in patients presenting with:

  • Stereotypical episodic vomiting (≥3 episodes annually)
  • Cannabis use for >1 year before symptom onset
  • Cannabis use frequency >4 times per week
  • Relief from hot showers/baths (reported in 71% of cases)
  • Resolution of symptoms after cannabis cessation 2, 1

Acute Management

First-line interventions:

  • IV fluid rehydration to correct dehydration and electrolyte abnormalities
  • Dopamine receptor antagonists:
    • Haloperidol 0.5-2 mg IV or PO every 4-6 hours 1
  • Topical capsaicin cream (0.1%) applied to abdomen with monitoring for efficacy and adverse effects 2, 1
  • Encourage hot showers/baths which provide temporary symptom relief 1

Second-line options:

  • Benzodiazepines: Lorazepam 0.5-2 mg PO/SL/IV every 6 hours 1, 3
  • Olanzapine: 5-10 mg PO daily 1
  • Promethazine for nausea control 4
  • Ondansetron may provide some benefit 2

Important cautions:

  • Avoid opioids due to risk of worsening nausea and high addiction potential 2
  • Provide a quiet, supportive environment with minimal stimulation 1
  • Ensure adequate hydration throughout treatment 1

Long-term Management

  1. Cannabis cessation counseling - the only definitive treatment 2, 1, 3
  2. Tricyclic antidepressants (e.g., amitriptyline):
    • Start at 25 mg at bedtime
    • Titrate weekly to reach minimal effective dose (75-100 mg) 2, 5
  3. Patient education about the direct relationship between cannabis use and symptoms
  4. Regular follow-up to monitor for symptom recurrence and cannabis use

Clinical Pearls

  • CHS is frequently misdiagnosed, leading to unnecessary testing and treatments 4
  • The paradoxical relief with hot water bathing/showering is a distinctive feature that helps differentiate CHS from other causes of cyclic vomiting 6
  • Symptoms typically resolve completely within 7-10 days of cannabis cessation 1
  • Capsaicin may reduce the need for additional medications and decrease opioid requirements 7
  • Emergency department differential diagnosis should include life-threatening conditions such as acute abdomen, bowel obstruction, mesenteric ischemia, pancreatitis, and myocardial infarction 2

Treatment Challenges

  • Many standard antiemetics show limited efficacy in CHS 5
  • Patient resistance to accepting cannabis as the cause of symptoms is common
  • High recurrence rate if cannabis use is resumed
  • Limited high-quality research on optimal pharmacologic treatment 3, 5

The most recent evidence strongly supports a multifaceted approach with cannabis cessation as the cornerstone of treatment, supplemented by dopamine antagonists, benzodiazepines, and topical capsaicin for symptomatic relief during acute episodes 2, 1.

References

Guideline

Medical Considerations for Cannabinoid Use

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.